EMAIL THIS PAGE TO A FRIEND

The Journal of Infectious Diseases

Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286.


PMID 25214516

Abstract

We're sorry this abstract is currently not available.